IRIDEX Corporation Q4 2025 Earnings Call Summary

What: IRIDEX Corporation reported Q4 2025 revenue of $**24.8 million**, a **3.5%** increase from Q4 2024.
Why: The growth was driven by strong sales of its Cyclo G6 laser system in the ophthalmology market.
Signal: The company's gross margin expanded to **73.2%**, up from **71.5%** in Q4 2024.
Target: IRIDEX Corporation guided Q1 2026 revenue to be in the range of $**25.5 million** to $**26.5 million**, representing a **4-6%** increase year-over-year.
Risk: The company faces intense competition in the ophthalmology market, which may impact future revenue growth.